Constarium
← Search

Data · dataset · 2025

Data for: Rodent biodistribution and dosimetry of the PET radioligands [18F]CHDI-386 targeting mutant huntingtin aggregates

Listed in Teesside University Research Data Repository

Huntington's disease is a neurodegenerative condition resulting from an expanded CAG repeat in the huntingtin gene that produces a mutant form of the huntingtin protein (mHTT).

Description

In this study we estimated the radiation safety of two structurally related mHTT radioligands, [18F]CHDI-385 and [18F]CHDI-386, by evaluating the in vivo and ex vivo dosimetry of both radioligands using CD-1 Swiss mice. We used adult male and female CD-1 Swiss mice (n = 15 per sex/radioligand) to assess in vivo positron emission tomography/computed tomography (PET/CT) imaging-based and ex vivo biodistribution-based tracer distribution of the radioligands at 30-, 60-, 120-, 240-, and 360-minutes post-radioligand injection.

Organ activity was quantified, and the residence time was extrapolated to human phantoms. The absorbed and effective doses were estimated using OLINDA/EXM 2.2 and IDAC-Dose2.1. Both radioligands, [18F]CHDI-385 and [18F]CHDI-386, showed high uptake in the gallbladder and urinary bladder, with a slow washout in most organs.

Read the rest (2 more)

The colon wall received the highest equivalent organ dose for both modalities. Ex vivo effective dose estimates were 15.4 μSv/MBq for [18F]CHDI-385 and 16.3 μSv/MBq for [18F]CHDI-386, while in vivo effective dose estimates were 18.5 μSv/MBq and 18.7 μSv/MBq, respectively. [18F]CHDI-385 and [18F]CHDI-386 dosimetry results showed absorbed and effective doses in acceptable range and below the recommended limits.

An injection of 370 MBq (10 mCi) in humans is estimated to result in highest (in vivo) effective doses of 6.85 mSv for [18F]CHDI-385 and 6.92 mSv for [18F]CHDI-386. This datasets has both in vivo and ex vivo data shared for [18F]CHDI-386.

Links

Where it is published

Catalogue records · 1

Topics

Inferred from text
Computed tomography 75% · Disease 75%
Provenance · 1 source records, 12 field assertions
SourceKeyLast seenRaw
Teesside University Research Data Repositoryoai:data.mendeley.com/gm48j9j25d.19 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0
concepts[disease].local:disease:diseaseenrichment · researchdata tees ac ukkeyword-concept-rules@1.0.0title+description (75%)
concepts[field].local:field:earth-environmentalmapping · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0
concepts[field].local:field:engineeringmapping · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0
concepts[field].local:field:humanitiesmapping · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0
concepts[field].local:field:life-sciencesmapping · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0
concepts[field].local:field:social-sciencemapping · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0
concepts[modality].local:modality:ctenrichment · researchdata tees ac ukkeyword-concept-rules@1.0.0title+description (75%)
descriptionsource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0/metadata/dc/description
licensesource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0/metadata/dc/rights
publication_datesource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0
titlesource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0/metadata/dc/title